Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (27)

2022

  1. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

  2. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  3. Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)

    PLoS ONE, Vol. 17, Núm. 12 December

2021

  1. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

2019

  1. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1

2018

  1. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

    Medical Mycology, Vol. 56, pp. S42-S59

2013

  1. Incidencia etaria y geográfica y patrón de sensibilidad a los antifúngicos de las especies de Candida causantes de candidemia en la población pediátrica española

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 6, pp. 363-368

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

2011

  1. Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study.

    Revista Iberoamericana de Micologia, Vol. 28, Núm. 2, pp. 91-99

  2. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  3. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

  4. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

2010

  1. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: A comparison with the M27-A3 reference method

    Medical Mycology, Vol. 48, Núm. 5, pp. 710-719

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Update on invasive fungal infections: the last two years

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27

2004

  1. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts

    Revista Iberoamericana de Micologia, Vol. 21, Núm. 2, pp. 63-69

2002

  1. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species

    Chemotherapy, Vol. 48, Núm. 1, pp. 21-25

2000

  1. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

    Chemotherapy, Vol. 46, Núm. 4, pp. 235-244

  2. In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 8, pp. 645-648